20 May 2024
20 May 2024
Type 2 Diabetes Prevention Week 2024, which starts on 20 May, shines a spotlight on the mental impact of living with the condition.
Boston Scientific has said that a trial examining its cardiac rhythm management technology saw 97.5% of patients walking away with no complications.
The company completed the final $5m tranche of its $77m Series C investment to expedite product launches.
The Affera Sphere-9 Catheter trial met its primary safety and efficacy endpoints.
The Implicity’s SignalHF1 algorithm can predict heart failure risks using data from cardiac devices.
The collaboration will see the integration of ZEPHYRx's remote spirometry platform with Morgan’s ComPAS2 PFT software.
Biomed 2024: The 22nd National Life Science & Technology Week is taking place in Tel Aviv, Israel from 21 to 23 May.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
